Evidence map›Paper›PMID 40638034›Full record

ArticleDiscover oncology2025

Somatostatin receptor expression in multiple hemangiomas.

Benjin Liu, Shangjian Li, Yisi Xu, Xuqi Huang, Xudong Guo, Hanbo Wang, Shaobo Jiang

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Benjin LiuDepartment of Urology, Shandong Provincial Hospital Affiliated with Shandong First Medical University, Jinan, China.
Shangjian LiDepartment of Urology, Shandong Provincial Hospital Affiliated with Shandong First Medical University, Jinan, China.
Yisi XuDepartment of Urology, Shandong Provincial Hospital Affiliated with Shandong First Medical University, Jinan, China.
Xuqi HuangDepartment of Urology, Shandong Provincial Hospital Affiliated with Shandong First Medical University, Jinan, China.
Xudong GuoDepartment of Urology, Shandong Provincial Hospital Affiliated with Shandong First Medical University, Jinan, China.
Hanbo WangDepartment of Urology, Shandong Provincial Hospital Affiliated with Shandong First Medical University, Jinan, China.
Shaobo JiangDepartment of Urology, Shandong Provincial Hospital Affiliated with Shandong First Medical University, Jinan, China. jiangshaobo1970@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough hemangiomas frequently occur in the skin, mucosa, liver, and brain, they are rarely observed in the abdominal cavity or retroperitoneum. Moreover, the expression of the somatostatin receptor (SSTR), a member of the G protein-coupled receptor superfamily, in hemangiomas is an uncommon phenomenon. Here, we report the case of a patient with hemangioma expressing somatostatin receptors. To date, this is the second documented case of multiple hemangiomas in which somatostatin receptors are expressed (Chua et al. Clin Nucl Med 47:321-323, 2022; Müssig et al. J Clin Endocrinol Metab 94:4123-4124, 2009). CASE PRESENTATION: A 66-year-old female with normal blood pressure and occasional episodes of hypertension but no symptoms, such as headache, chest pain, or palpitations, was found to have multiple hypervascular lesions in the retroperitoneum, rectouterine pouch, abdominal wall, and small bowel wall on pelvic contrast-enhanced CT. On the basis of the imaging findings from the CT and PET scans, the initial diagnosis was metastatic paraganglioma. The patient underwent laparoscopic surgery, and the tumors in the retroperitoneum and abdominal wall were successfully removed. Histopathological diagnosis confirmed hemangioma. Immunohistochemistry revealed positive expression of the endothelial cell markers CD31(+) and CD34(+), as well as expression of somatostatin receptor 2 (SSTR2), in some cytoplasmic cells.

conclusionThis case highlights the rare expression of somatostatin receptors in hemangiomas, which may provide insights into their biological behavior and potential therapeutic targets. Increased awareness of such atypical presentations can improve diagnostic accuracy and inform clinical management strategies.

Indexed as

68Ga-DOTATATE PET/CTHemangiomaNeuroendocrine tumorRetroperitoneumSomatostatin receptor

Identifiers

PMID40638034
PMCPMC12246323

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.